BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Diagnosis
822 results:

  • 1. PELI1: key players in the oncogenic characteristics of pancreatic cancer.
    Fei X; Zhu C; Liu P; Liu S; Ren L; Lu R; Hou J; Gao Y; Wang X; Pan Y
    J Exp Clin Cancer Res; 2024 Mar; 43(1):91. PubMed ID: 38528516
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A Machine Learning Method for a Blood Diagnostic Model of Pancreatic cancer Based on microRNA Signatures.
    Huang B; Xin C; Yan H; Yu Z
    Crit Rev Immunol; 2024; 44(3):13-23. PubMed ID: 38421702
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Deep response to a combination of mTOR inhibitor temsirolimus and dual immunotherapy of nivolumab/ipilimumab in poorly differentiated thyroid carcinoma with
    Oh Y; Park JH; Djunadi TA; Shah Z; Chung LI; Chae YK
    Front Endocrinol (Lausanne); 2024; 15():1304188. PubMed ID: 38356955
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinical value of multi-gene testing in distinguishing benign and malignant thyroid nodules.
    Zhang M; Hu X; Liu L; Wang Y; Jiang J; Li H; Fei W; Zhong T; Jiang Z
    Medicine (Baltimore); 2024 Jan; 103(4):e35960. PubMed ID: 38277563
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Epithelioid angiomyolipoma of the liver in a patient with Li-Fraumeni syndrome: a case report.
    Yang Y; Lee J; Woo CG; Lee OJ; Son SM
    Diagn Pathol; 2024 Jan; 19(1):16. PubMed ID: 38243242
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Phenotype analysis of families with tp53 germline variants at the Center for Familial Breast and Ovarian cancer, Cologne.
    Kast K; Rhiem K; Larsen M; Wappenschmidt B; Schmutzler R
    Cancer Med; 2024 Feb; 13(3):e6920. PubMed ID: 38230850
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Role of SLC7A11/xCT in Ovarian cancer.
    Fantone S; Piani F; Olivieri F; Rippo MR; Sirico A; Di Simone N; Marzioni D; Tossetta G
    Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203758
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer.
    Young Han C; Bedia JS; Yang WL; Hawley SJ; Bergan L; Hopper M; Celestino J; Guo J; Gornet TG; Soosaipillai A; Yang H; Doskocil SD; Lokshin AE; Handy BC; Diamandis EP; Moore RG; Lu KH; Lu Z; Anderson KS; Drescher CW; Skates SJ; Bast RC
    Br J Cancer; 2024 Mar; 130(5):861-868. PubMed ID: 38195887
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Adrenal cortical carcinoma in children: a clinicopathological analysis of 25 cases].
    Wang RF; Guan WB; Li LX; Qiao M; Jiang RQ; Wang LF
    Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):40-45. PubMed ID: 38178745
    [No Abstract]    [Full Text] [Related]  

  • 10. [Practical application of immunohistochemistry in pancreatic neuroendocrine neoplasms : Tips and pitfalls].
    Bräutigam K; Chouchane A; Konukiewitz B; Perren A
    Pathologie (Heidelb); 2024 Feb; 45(1):35-41. PubMed ID: 38175232
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Molecular characteristics of early-onset pancreatic ductal adenocarcinoma.
    Debernardi S; Liszka L; Ntala C; Steiger K; Esposito I; Carlotti E; Baker AM; McDonald S; Graham T; Dmitrovic B; Feakins RM; Crnogorac-Jurcevic T
    Mol Oncol; 2024 Mar; 18(3):677-690. PubMed ID: 38145461
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Precision medicine for KRAS wild-type pancreatic adenocarcinomas.
    Ben-Ammar I; Rousseau A; Nicolle R; Tarabay A; Boige V; Valery M; Pudlarz T; Malka D; Gelli M; Fernandez-De-Sevilla E; Fuerea A; Tanguy ML; Rouleau E; Barbe R; Mathieu JRR; Jaulin F; Smolenschi C; Hollebecque A; Ducreux M; Boileve A
    Eur J Cancer; 2024 Jan; 197():113497. PubMed ID: 38134480
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Comprehensive review of pancreatic acinar cell carcinoma: epidemiology, diagnosis, molecular features and treatment.
    Ikezawa K; Urabe M; Kai Y; Takada R; Akita H; Nagata S; Ohkawa K
    Jpn J Clin Oncol; 2024 Mar; 54(3):271-281. PubMed ID: 38109477
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Identifying Explainable Machine Learning Models and a Novel SFRP2
    Yang Z; Zhou D; Huang J
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069266
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Genomic instability analysis in DNA from Papanicolaou test provides proof-of-principle early diagnosis of high-grade serous ovarian cancer.
    Paracchini L; Mannarino L; Romualdi C; Zadro R; Beltrame L; Fuso Nerini I; Zola P; Laudani ME; Pagano E; Giordano L; Fruscio R; Landoni F; Franceschi S; Dalessandro ML; Canzonieri V; Bocciolone L; Lorusso D; Bosetti C; Raspagliesi F; Garassino IMG; ; D'Incalci M; Marchini S
    Sci Transl Med; 2023 Dec; 15(725):eadi2556. PubMed ID: 38055801
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Identification of key genes and pathways in adrenocortical carcinoma: evidence from bioinformatic analysis.
    Yin M; Wang Y; Ren X; Han M; Li S; Liang R; Wang G; Gang X
    Front Endocrinol (Lausanne); 2023; 14():1250033. PubMed ID: 38053725
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Aneuploidy Landscape in Precursors of Ovarian cancer.
    Wang Y; Douville C; Chien YW; Wang BG; Chen CL; Pinto A; Smith SA; Drapkin R; Chui MH; Numan T; Vang R; Papadopoulos N; Wang TL; Shih IM
    Clin Cancer Res; 2024 Feb; 30(3):600-615. PubMed ID: 38048050
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Serial Circulating Tumor DNA Analysis with a Tumor-Naïve Next-Generation Sequencing Panel Detects Minimal Residual Disease and Predicts Outcome in Ovarian cancer.
    Heo J; Kim YN; Shin S; Lee K; Lee JH; Lee YJ; Choi Z; Park J; Min S; Kim SW; Choi JR; Kim S; Lee ST; Lee JY
    Cancer Res; 2024 Feb; 84(3):468-478. PubMed ID: 38038965
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Preoperative ctDNA Levels Are Associated With Poor Overall Survival in Patients With Ovarian cancer.
    Dobilas A; Chen Y; Brueffer C; Leandersson P; Saal LH; Borgfeldt C
    Cancer Genomics Proteomics; 2023 Dec; 20(6suppl):763-770. PubMed ID: 38035709
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Mutant p53 murine oviductal epithelial cells induce progression of high-grade serous carcinoma and are most sensitive to simvastatin therapy in vitro and in vivo.
    Pereira M; Glogova A; Haagsma J; Stewart J; Shepherd TG; Petrik J
    J Ovarian Res; 2023 Nov; 16(1):218. PubMed ID: 37986175
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 42.